Published in Development on February 27, 2008
Ror2 receptor requires tyrosine kinase activity to mediate Wnt5A signaling. J Biol Chem (2009) 1.52
Type IV collagen drives alveolar epithelial-endothelial association and the morphogenetic movements of septation. BMC Biol (2016) 1.42
Wntless is required for peripheral lung differentiation and pulmonary vascular development. Dev Biol (2013) 1.03
Congenital diaphragmatic hernia candidate genes derived from embryonic transcriptomes. Proc Natl Acad Sci U S A (2012) 1.01
Wnt to build a tube: contributions of Wnt signaling to epithelial tubulogenesis. Dev Dyn (2010) 1.00
Lipid phosphate phosphatase 3 stabilization of beta-catenin induces endothelial cell migration and formation of branching point structures. Mol Cell Biol (2010) 0.96
Asthma and pulmonary arterial hypertension: do they share a key mechanism of pathogenesis? Eur Respir J (2010) 0.95
Sonic hedgehog is required for vascular outgrowth in the hindbrain choroid plexus. Dev Biol (2010) 0.94
Loss of cilia causes embryonic lung hypoplasia, liver fibrosis, and cholestasis in the talpid3 ciliopathy mutant. Organogenesis (2014) 0.93
Mullerian inhibiting substance inhibits invasion and migration of epithelial cancer cell lines. Gynecol Oncol (2010) 0.90
Mammary branch initiation and extension are inhibited by separate pathways downstream of TGFβ in culture. Exp Cell Res (2011) 0.89
An ENU-mutagenesis screen in the mouse: identification of novel developmental gene functions. PLoS One (2011) 0.88
Separate and distinctive roles for Wnt5a in tongue, lingual tissue and taste papilla development. Dev Biol (2011) 0.83
Wnt5a through noncanonical Wnt/JNK or Wnt/PKC signaling contributes to the differentiation of mesenchymal stem cells into type II alveolar epithelial cells in vitro. PLoS One (2014) 0.82
Development and remodeling of the vertebrate blood-gas barrier. Biomed Res Int (2012) 0.82
Canonical Wnt signaling activity in early stages of chick lung development. PLoS One (2014) 0.77
WNT5a in tongue and fungiform Papilla development. Ann N Y Acad Sci (2009) 0.76
Expression of WNT5A in Idiopathic Pulmonary Fibrosis and Its Control by TGF-β and WNT7B in Human Lung Fibroblasts. J Histochem Cytochem (2015) 0.76
MiR-449a Affects Epithelial Proliferation during the Pseudoglandular and Canalicular Phases of Avian and Mammal Lung Development. PLoS One (2016) 0.76
Non-canonical WNT signalling in the lung. J Biochem (2015) 0.76
Genetic tools and algorithms for gene discovery in major congenital anomalies. Birth Defects Res A Clin Mol Teratol (2009) 0.76
Blood vessel crosstalk during organogenesis-focus on pancreas and endothelial cells. Wiley Interdiscip Rev Dev Biol (2016) 0.76
Expression analysis of Shh signaling members in early stages of chick lung development. Histochem Cell Biol (2016) 0.76
A pediatric surgeon retools in genetics and genomics to study congenital diaphragmatic hernia. J Pediatr Surg (2009) 0.75
Induction of WNT inhibitory factor 1 expression by Müllerian inhibiting substance/antiMullerian hormone in the Müllerian duct mesenchyme is linked to Müllerian duct regression. Dev Biol (2013) 0.75
Retinoic acid regulates avian lung branching through a molecular network. Cell Mol Life Sci (2017) 0.75
Detection of large-scale variation in the human genome. Nat Genet (2004) 49.18
Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature (2003) 10.33
Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages. Nature (2009) 4.68
Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness. Proc Natl Acad Sci U S A (2006) 4.66
A large-scale analysis of tissue-specific pathology and gene expression of human disease genes and complexes. Proc Natl Acad Sci U S A (2008) 3.57
Comprehensive assessment of array-based platforms and calling algorithms for detection of copy number variants. Nat Biotechnol (2011) 3.25
Sex determination and differentiation. N Engl J Med (2004) 3.07
Improvement of pathology in sub-Saharan Africa. Lancet Oncol (2013) 2.88
CD133 expression defines a tumor initiating cell population in primary human ovarian cancer. Stem Cells (2009) 2.76
Indian Hedgehog is an antagonist of Wnt signaling in colonic epithelial cell differentiation. Nat Genet (2004) 2.59
Case records of the Massachusetts General Hospital: Case 34-2012: a 27-year-old woman in Ethiopia with severe pain, bleeding, and shock during labor. N Engl J Med (2012) 2.58
Conditional deletion of beta-catenin in the mesenchyme of the developing mouse uterus results in a switch to adipogenesis in the myometrium. Dev Biol (2005) 2.07
Case records of the Massachusetts General Hospital. Case 12-2008. A newborn infant with intermittent apnea and seizures. N Engl J Med (2008) 2.04
A dermal HOX transcriptional program regulates site-specific epidermal fate. Genes Dev (2008) 1.85
Mutations in LRP2, which encodes the multiligand receptor megalin, cause Donnai-Barrow and facio-oculo-acoustico-renal syndromes. Nat Genet (2007) 1.85
Relative roles of TGF-beta1 and Wnt in the systemic regulation and aging of satellite cell responses. Aging Cell (2009) 1.72
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 25-2003. A newborn boy with petechiae and thrombocytopenia. N Engl J Med (2003) 1.59
HOXB9, a gene overexpressed in breast cancer, promotes tumorigenicity and lung metastasis. Proc Natl Acad Sci U S A (2009) 1.45
Fetal vascular obstructive lesions: nosology and reproducibility of placental reaction patterns. Pediatr Dev Pathol (2004) 1.44
Case records of the Massachusetts General Hospital. Case 27-2007. A 30-year-old pregnant woman with intrauterine fetal death. N Engl J Med (2007) 1.42
BMP signaling is necessary for neural crest cell migration and ganglion formation in the enteric nervous system. Mech Dev (2005) 1.42
Normal ovarian surface epithelial label-retaining cells exhibit stem/progenitor cell characteristics. Proc Natl Acad Sci U S A (2008) 1.41
Dissecting spatio-temporal protein networks driving human heart development and related disorders. Mol Syst Biol (2010) 1.35
Müllerian inhibiting substance regulates its receptor/SMAD signaling and causes mesenchymal transition of the coelomic epithelial cells early in Müllerian duct regression. Development (2006) 1.26
The immunophilin FKBP12: a molecular guardian of the TGF-beta family type I receptors. Front Biosci (2004) 1.25
Human ovarian cancer stem/progenitor cells are stimulated by doxorubicin but inhibited by Mullerian inhibiting substance. Proc Natl Acad Sci U S A (2012) 1.21
Mullerian inhibiting substance preferentially inhibits stem/progenitors in human ovarian cancer cell lines compared with chemotherapeutics. Proc Natl Acad Sci U S A (2010) 1.20
Endogenous patterns of BMP signaling during early chick development. Dev Biol (2002) 1.19
Adult mouse myometrial label-retaining cells divide in response to gonadotropin stimulation. Stem Cells (2007) 1.18
Management and long-term follow-up of patients with types III and IV laryngotracheoesophageal clefts. J Pediatr Surg (2005) 1.17
Highly purified müllerian inhibiting substance inhibits human ovarian cancer in vivo. Clin Cancer Res (2002) 1.15
Mullerian inhibiting substance acts as a motor neuron survival factor in vitro. Proc Natl Acad Sci U S A (2005) 1.14
Hh pathway expression in human gut tissues and in inflammatory gut diseases. Lab Invest (2004) 1.13
MIS/AMH in the assessment of cryptorchidism and intersex conditions. Mol Cell Endocrinol (2003) 1.11
Stromal deletion of the APC tumor suppressor in mice triggers development of endometrial cancer. Cancer Res (2011) 1.10
Genetic and environmental risk factors in congenital heart disease functionally converge in protein networks driving heart development. Proc Natl Acad Sci U S A (2012) 1.08
Persistent Mullerian duct syndrome caused by both a 27-bp deletion and a novel splice mutation in the MIS type II receptor gene. Birth Defects Res A Clin Mol Teratol (2003) 1.07
Expression of progesterone receptor membrane component 1 and its partner serpine 1 mRNA binding protein in uterine and placental tissues of the mouse and human. Mol Cell Endocrinol (2008) 1.07
Infants with Bochdalek diaphragmatic hernia: sibling precurrence and monozygotic twin discordance in a hospital-based malformation surveillance program. Am J Med Genet A (2005) 1.06
Mammalian target of rapamycin is a therapeutic target for murine ovarian endometrioid adenocarcinomas with dysregulated Wnt/β-catenin and PTEN. PLoS One (2011) 1.04
SOX9 specifies the pyloric sphincter epithelium through mesenchymal-epithelial signals. Development (2004) 1.03
Association of epidural-related fever and noninfectious inflammation in term labor. Obstet Gynecol (2011) 1.02
Recombinant human Mullerian inhibiting substance inhibits long-term growth of MIS type II receptor-directed transgenic mouse ovarian cancers in vivo. Clin Cancer Res (2006) 1.02
Mullerian Inhibiting Substance enhances subclinical doses of chemotherapeutic agents to inhibit human and mouse ovarian cancer. Proc Natl Acad Sci U S A (2006) 1.02
Synergism of verbal autopsy and diagnostic pathology autopsy for improved accuracy of mortality data. Popul Health Metr (2011) 1.01
Intersex genetic anomalies with malignant potential. Curr Opin Pediatr (2006) 1.01
Congenital diaphragmatic hernia candidate genes derived from embryonic transcriptomes. Proc Natl Acad Sci U S A (2012) 1.01
New approaches for high-yield purification of Müllerian inhibiting substance improve its bioactivity. J Chromatogr B Analyt Technol Biomed Life Sci (2002) 1.00
Tail gut endoderm and gut/genitourinary/tail development: a new tissue-specific role for Hoxa13. Development (2002) 1.00
Endometrial cancer is a receptor-mediated target for Mullerian Inhibiting Substance. Proc Natl Acad Sci U S A (2004) 0.99
Congenital diaphragmatic hernia (CDH) etiology as revealed by pathway genetics. Am J Med Genet C Semin Med Genet (2007) 0.99
Mullerian-inhibiting substance regulates NF-kappa B signaling in the prostate in vitro and in vivo. Proc Natl Acad Sci U S A (2002) 0.99
Mullerian Inhibiting Substance inhibits cervical cancer cell growth via a pathway involving p130 and p107. Proc Natl Acad Sci U S A (2003) 0.98
Feedback inhibition of steroidogenic acute regulatory protein expression in vitro and in vivo by androgens. Endocrinology (2003) 0.98
Donnai-Barrow syndrome (DBS/FOAR) in a child with a homozygous LRP2 mutation due to complete chromosome 2 paternal isodisomy. Am J Med Genet A (2008) 0.96
MEK-1/2 inhibition reduces branching morphogenesis and causes mesenchymal cell apoptosis in fetal rat lungs. Am J Physiol Lung Cell Mol Physiol (2002) 0.96
Müllerian inhibiting substance/anti-Müllerian hormone: a potential therapeutic agent for human ovarian and other cancers. Future Oncol (2010) 0.95
c-Jun N-terminal kinase inhibitor II (SP600125) activates Mullerian inhibiting substance type II receptor-mediated signal transduction. Endocrinology (2007) 0.92
Uterine leiomyomas exhibit fewer stem/progenitor cell characteristics when compared with corresponding normal myometrium. Reprod Sci (2009) 0.92
Bone morphogenetic protein signaling pathway plays multiple roles during gastrointestinal tract development. Dev Dyn (2005) 0.92
Placental pathology in egg donor pregnancies. Fertil Steril (2009) 0.91
Focal Mullerian duct retention in male mice with constitutively activated beta-catenin expression in the Mullerian duct mesenchyme. Proc Natl Acad Sci U S A (2010) 0.90
Mullerian inhibiting substance inhibits invasion and migration of epithelial cancer cell lines. Gynecol Oncol (2010) 0.90
Characterization of the chromosome 1q41q42.12 region, and the candidate gene DISP1, in patients with CDH. Am J Med Genet A (2010) 0.90
Congenital diaphragmatic hernia interval on chromosome 8p23.1 characterized by genetics and protein interaction networks. Am J Med Genet A (2012) 0.89
High prevalence of hypertension and placental insufficiency, but no in utero HIV transmission, among women on HAART with stillbirths in Botswana. PLoS One (2012) 0.89
Mullerian inhibiting substance: an update. Adv Exp Med Biol (2002) 0.88
Mullerian inhibiting substance promotes interferon gamma-induced gene expression and apoptosis in breast cancer cells. J Biol Chem (2003) 0.88
Cell migration and activated PI3K/AKT-directed elongation in the developing rat Müllerian duct. Dev Biol (2008) 0.87
Congenital adrenal hyperplasia: surgical considerations required to repair a 46,XX patient raised as a boy. J Pediatr Surg (2003) 0.86
Mullerian-inhibiting substance induces Gro-beta expression in breast cancer cells through a nuclear factor-kappaB-dependent and Smad1-dependent mechanism. Cancer Res (2007) 0.85
Measurement of Mullerian inhibiting substance facilitates management of boys with microphallus and cryptorchidism. J Clin Endocrinol Metab (2002) 0.85
Differential epithelial expression of SHH and FOXF1 in usual and nonspecific interstitial pneumonia. Exp Mol Pathol (2006) 0.84
Mullerian inhibiting substance regulates androgen-induced gene expression and growth in prostate cancer cells through a nuclear factor-kappaB-dependent Smad-independent mechanism. Mol Endocrinol (2006) 0.83
Expression analysis and evolutionary conservation of the mouse germ cell-specific D6Mm5e gene. Dev Dyn (2006) 0.82
Mullerian inhibiting substance induces apoptosis of human endometrial stromal cells in endometriosis. J Clin Endocrinol Metab (2012) 0.82
High rate of placental infarcts in type 2 compared with type 1 diabetes. J Clin Endocrinol Metab (2012) 0.81
Distribution of ERK1/2 and ERK3 during normal rat fetal lung development. Anat Embryol (Berl) (2005) 0.81
Müllerian-inhibiting substance inhibits rat Leydig cell regeneration after ethylene dimethanesulphonate ablation. Biol Reprod (2003) 0.81
Placental histomorphometry in gestational diabetes mellitus: the relationship between subsequent type 2 diabetes mellitus and race/ethnicity. Am J Clin Pathol (2014) 0.81
Triplet placentas: reference values for weights. Pediatr Dev Pathol (2002) 0.81
Steroidogenic activities in MA-10 Leydig cells are differentially altered by cAMP and Müllerian inhibiting substance. J Steroid Biochem Mol Biol (2004) 0.81
Diagnosis of hydatidiform moles by polymorphic deletion probe fluorescence in situ hybridization. J Mol Diagn (2011) 0.80
Development of an efficiently cleaved, bioactive, highly pure FLAG-tagged recombinant human Mullerian Inhibiting Substance. Protein Expr Purif (2009) 0.79
Placental histopathologic features in patients with thrombophilic mutations. J Matern Fetal Neonatal Med (2007) 0.78
Enteric nervous system patterning in the avian hindgut. Dev Dyn (2004) 0.78
Placental villitis of unclear etiology during ovum donor in vitro fertilization pregnancy. Am J Obstet Gynecol (2003) 0.78
Wnt signaling during Caenorhabditis elegans embryonic development. Methods Mol Biol (2008) 0.77
Müllerian inhibiting substance is anterogradely transported and does not attenuate avulsion-induced death of hypoglossal motor neurons. Exp Neurol (2010) 0.77
Identification of characteristic molecular signature of Müllerian inhibiting substance in human HPV-related cervical cancer cells. Int J Oncol (2011) 0.77
Genetic tools and algorithms for gene discovery in major congenital anomalies. Birth Defects Res A Clin Mol Teratol (2009) 0.76
The role of Müllerian inhibiting substance in the evaluation of phenotypic female patients with mild degrees of virilization. J Clin Endocrinol Metab (2003) 0.76
Genomic structure and expression analysis of the mouse testis-specific ribbon protein (Trib) gene. Gene (2004) 0.76
Placental Pathology Associated with Household Air Pollution in a Cohort of Pregnant Women from Dar es Salaam, Tanzania. Environ Health Perspect (2016) 0.75
Expression of Müllerian inhibiting substance type II receptor and antiproliferative effects of MIS on human cervical cancer. Int J Oncol (2012) 0.75
Improving diagnostic pathology capacity for global cancer care: where to start. Am J Clin Pathol (2014) 0.75
Sexual dimorphism of G-protein subunit Gng13 expression in the cortical region of the developing mouse ovary. Dev Dyn (2007) 0.75
In reply. Arch Pathol Lab Med (2014) 0.75
Meiosis I arrest abnormalities lead to severe oligozoospermia in meiosis 1 arresting protein (M1ap)-deficient mice. Biol Reprod (2013) 0.75